GHK-Cu

✓Key benefits

📈What to expect

Based on community reports and published research. Individual results vary significantly.

💊Dosing protocols

Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.

Overview

GHK-Cu (Glycyl-L-Histidyl-L-Lysine bound to copper) is a tripeptide-copper complex naturally found in human plasma, saliva, and urine. Discovered in 1973 by Dr. Loren Pickart, it was initially identified for its ability to make liver tissue from older individuals behave like younger tissue. GHK-Cu plasma levels decline significantly with age - from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. This decline correlates with reduced wound healing, collagen production, and skin quality. It has been shown to affect the expression of over 4,000 human genes, with a strong bias toward restoring gene expression patterns to a younger state.

⚙️How it works

GHK-Cu works through multiple mechanisms. It promotes collagen synthesis (types I and III), decorin production, and glycosaminoglycan formation. It attracts immune cells and fibroblasts to wound sites, promotes angiogenesis, and has potent anti-inflammatory effects. At the gene level, it upregulates genes involved in tissue remodelling and DNA repair while downregulating genes associated with inflammation and tissue destruction. The copper ion in the complex also plays a role in superoxide dismutase activity, contributing to antioxidant defence.

⚡Side effects

📅Research history

Vendor ratings are based on community feedback and are not endorsements. Always verify third-party certificates of analysis (CoA) and check current Australian regulations before purchasing.

The age-related decline

One of the most compelling aspects of GHK-Cu is the well-documented decline in plasma levels with age. At 20 years old, average plasma GHK-Cu is approximately 200 ng/mL. By 60, this drops to around 80 ng/mL - a 60% decline. This correlates directly with the visible signs of aging: reduced wound healing speed, thinner skin, decreased collagen production, and slower recovery. The logic behind GHK-Cu supplementation is straightforward: restore levels of a compound your body naturally produces less of with age.

Topical vs systemic

GHK-Cu is available in two main forms: topical (creams, serums) and injectable. Topical products (typically 1–3% concentration) are the most accessible and are available in many skincare lines. They primarily benefit the skin and hair at the application site. Injectable GHK-Cu provides systemic effects - the gene expression modulation, anti-inflammatory benefits, and internal tissue remodelling that topical application cannot reach. Many in the community use both: topical for targeted skin/hair benefits, injectable for broader anti-aging effects.

Gene expression research

Perhaps the most remarkable finding about GHK-Cu is its effect on gene expression. A 2014 study by Pickart et al. used the Broad Institute's Connectivity Map to show that GHK-Cu affects the activity of 4,048 human genes - approximately 6% of the human genome. The direction of these changes consistently shifted gene expression toward patterns seen in younger individuals. This included upregulation of DNA repair genes, collagen and elastin genes, and antioxidant response genes, while downregulating genes associated with inflammation, fibrosis, and cancer metastasis.

References

1. [1]Pickart L, et al. "GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration." BioMed Research International, 2015.
2. [2]Pickart L, Margolina A. "Regenerative and protective actions of GHK-Cu peptide." International Journal of Molecular Sciences, 2018.
3. [3]Pollard JD, et al. "Synthetic GHK-Cu promotes healing of bone and tendon." Journal of Experimental Therapeutics and Oncology, 2005.
4. [4]Campbell JD, et al. "Wound healing effects of GHK-Cu." Journal of Cosmetic Dermatology, 2012.

Frequently asked questions

Related peptides